Cellyan Biotechnology held extraordinary shareholder meeting, quorum reached
Bitget2026/09/23 13:10- Cellyan Biotechnology held an extraordinary general meeting of shareholders on Sept. 21, 2026.
- Shareholders backed a 1-for-20 consolidation of Class A and Class B ordinary shares, subject to Nasdaq confirmation or no objection.
- The plan sets par value at US$0.02 per share, eliminates fractional shares via rounding up to one share.
- Investors also adopted a fifth amended memorandum and articles, contingent on the consolidation becoming effective.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Crypto prices
More
